PTGS2 and neoplasm: Ye et al. (2012) applied curcumin, lovastatin, and EGCG and investigated their combined effects in EC cell lines and mouse xenografts. The authors found that cell viability and tumor growth were inhibited upon the combined treatment via the downregulation of Erk1/2, c-Jun, and cyclooxygenase-2 expression.